Cargando…

Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice

Cardiac hypertrophy is necessary for the heart to accommodate an increase in workload. Physiological, compensated hypertrophy (e.g. with exercise) is reversible and largely due to cardiomyocyte hypertrophy. Pathological hypertrophy (e.g. with hypertension) is associated with additional features incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alharbi, Hajed O., Hardyman, Michelle A., Cull, Joshua J., Markou, Thomais, Cooper, Susanna T.E., Glennon, Peter E., Fuller, Stephen J., Sugden, Peter H., Clerk, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2022
Materias:	Cardiovascular System & Vascular Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679367/ https://www.ncbi.nlm.nih.gov/pubmed/36331065 http://dx.doi.org/10.1042/CS20220607

Ejemplares similares

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022)

The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension
por: Meijles, Daniel N., et al.
Publicado: (2021)

MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins
por: Fuller, Stephen J., et al.
Publicado: (2021)

The insulin receptor family and protein kinase B (Akt) are activated in the heart by alkaline pH and α(1)-adrenergic receptors
por: Meijles, Daniel N., et al.
Publicado: (2021)

The insulin receptor family in the heart: new light on old insights
por: Clerk, Angela, et al.
Publicado: (2022)

PKN2 deficiency leads both to prenatal ‘congenital’ cardiomyopathy and defective angiotensin II stress responses
por: Marshall, Jacqueline J.T., et al.
Publicado: (2022)

Central role for BRAF in cardiac hypertrophy: rethinking the pathological–physiological divide
por: Altara, Raffaele, et al.
Publicado: (2023)

Regulation of the cardiomyocyte transcriptome vs translatome by endothelin-1 and insulin: translational regulation of 5' terminal oligopyrimidine tract (TOP) mRNAs by insulin
por: Markou, Thomais, et al.
Publicado: (2010)

Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension
por: Meijles, Daniel N., et al.
Publicado: (2020)

Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling
por: Gao, Weinian, et al.
Publicado: (2020)

Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes
por: Cullingford, Timothy E, et al.
Publicado: (2008)

The cardiomyocyte “redox rheostat”: Redox signalling via the AMPK-mTOR axis and regulation of gene and protein expression balancing survival and death
por: Meijles, Daniel N., et al.
Publicado: (2019)

Monophosphothreonyl extracellular signal-regulated kinases 1 and 2 (ERK1/2) are formed endogenously in intact cardiac myocytes and are enzymically active
por: Sugden, Peter H., et al.
Publicado: (2011)

Corrigendum to “Monophosphothreonyl extracellular signal-regulated kinases 1 and 2 (ERK1/2) are formed endogenously in intact cardiac myocytes and are enzymically active” [Cell Signal 23 (2011) 468–477]
por: Sugden, Peter H., et al.
Publicado: (2011)

Role of CyPA in cardiac hypertrophy and remodeling
por: Cao, Mengfei, et al.
Publicado: (2019)

p90 Ribosomal S6 kinases play a significant role in early gene regulation in the cardiomyocyte response to G(q)-protein-coupled receptor stimuli, endothelin-1 and α(1)-adrenergic receptor agonists
por: Amirak, Emre, et al.
Publicado: (2013)

Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy
por: Wang, Zhao-Peng, et al.
Publicado: (2019)

Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes
por: Wu, Peng, et al.
Publicado: (2021)

Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy
por: Gao, Maomao, et al.
Publicado: (2020)

The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation
por: Cianflone, Eleonora, et al.
Publicado: (2022)

MiR-21 attenuates FAS-mediated cardiomyocyte apoptosis by regulating HIPK3 expression
por: Wang, Xinyu, et al.
Publicado: (2023)

Stimulation of the p38 Mitogen-activated Protein Kinase Pathway in Neonatal Rat Ventricular Myocytes by the G Protein–coupled Receptor Agonists, Endothelin-1 and Phenylephrine: A Role in Cardiac Myocyte Hypertrophy?
por: Clerk, Angela, et al.
Publicado: (1998)

MiR-489 aggravates H(2)O(2)-induced apoptosis of cardiomyocytes via inhibiting IGF1
por: Tang, Shan, et al.
Publicado: (2020)

The protective role of MiR-206 in regulating cardiomyocytes apoptosis induced by ischemic injury by targeting PTP1B
por: Yan, Yejun, et al.
Publicado: (2020)

Effect of miR-195-5p on cardiomyocyte apoptosis in rats with heart failure by regulating TGF-β1/Smad3 signaling pathway
por: Xie, Chun, et al.
Publicado: (2020)

Sappanone A alleviates hypoxia/reoxygenation-induced cardiomyocytes injury through inhibition of mitochondrial apoptosis and activation of PI3K–Akt–Gsk-3β pathway
por: Shi, Xiaojing, et al.
Publicado: (2020)

Feedback regulation by Atf3 in the endothelin-1-responsive transcriptome of cardiomyocytes: Egr1 is a principal Atf3 target
por: Giraldo, Alejandro, et al.
Publicado: (2012)

ERK1/2 Signaling Dominates Over RhoA Signaling in Regulating Early Changes in RNA Expression Induced by Endothelin-1 in Neonatal Rat Cardiomyocytes
por: Marshall, Andrew K., et al.
Publicado: (2010)

Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation
por: Hessel, M. H. M., et al.
Publicado: (2007)

Epidermal growth factor signaling through transient receptor potential melastatin 7 cation channel regulates vascular smooth muscle cell function
por: Zou, Zhi-Guo, et al.
Publicado: (2020)

Correlation of Coronary Artery Disease and Left Ventricular Hypertrophy
por: Khalid, Khizer, et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy
por: Kooij, Viola, et al.
Publicado: (2016)

Commentary on: Increased stiffness of omental arteries from late pregnant women at advanced maternal age
por: Stanhewicz, Anna E., et al.
Publicado: (2023)

Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death
por: Zhong, Xiaowei, et al.
Publicado: (2021)

Mechanism-based strategies to prevent salt sensitivity and salt-induced hypertension
por: Kurtz, Theodore W., et al.
Publicado: (2022)

Notch3 signalling and vascular remodelling in pulmonary arterial hypertension
por: Morris, Hannah E., et al.
Publicado: (2019)

Role of B lymphocytes in the infarcted mass in patients with acute myocardial infarction
por: Casarotti, Ana C.A., et al.
Publicado: (2021)

Genetic architecture of heart mitochondrial proteome influencing cardiac hypertrophy
por: Chella Krishnan, Karthickeyan, et al.
Publicado: (2023)

Calpain-2 specifically cleaves Junctophilin-2 at the same site as Calpain-1 but with less efficacy
por: Wang, Jinxi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pbp0s3iv3r4t1pnomtam5008t0